What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for treating infections, particularly in patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for most infections is one double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) every 12 hours for 10-14 days, or one regular-strength tablet (80 mg trimethoprim/400 mg sulfamethoxazole) every 12 hours. However, for patients with impaired renal function, dosage adjustments are necessary.

Key Considerations

  • For those with creatinine clearance between 15-30 mL/min, the recommended dose is half the normal dose 1.
  • For patients with creatinine clearance below 15 mL/min, Bactrim is generally not recommended, or the dose should be reduced to half the normal dose or an alternative agent should be used 1.

Dosing Adjustments

  • Dosing should be based on the patient's weight, severity of infection, and renal function.
  • Adequate hydration is important during treatment to prevent crystalluria.

Mechanism of Action

  • Bactrim works by inhibiting two consecutive steps in bacterial folate synthesis - sulfamethoxazole blocks the incorporation of para-aminobenzoic acid into dihydrofolic acid, while trimethoprim inhibits dihydrofolate reductase, preventing the formation of tetrahydrofolic acid.
  • This dual mechanism provides synergistic antibacterial activity but also increases the risk of adverse effects in patients with kidney dysfunction due to reduced drug clearance.

Recent Guidelines

  • Recent guidelines from the American College of Physicians suggest that short-course antibiotics, including trimethoprim-sulfamethoxazole, can be effective for treating uncomplicated urinary tract infections 1.

From the FDA Drug Label

The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim double strength tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days For Patients with Impaired Renal Function When renal function is impaired, a reduced dosage should be employed using the following table: Creatinine Clearance (mL/min) Recommended Dosage Regimen Above 30 Usual standard regimen 15 to 30 ½ the usual regimen Below 15 Use not recommended

The recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for treating infections is:

  • 1 double strength tablet or 2 single strength tablets every 12 hours for 10 to 14 days for urinary tract infections in adults.
  • For patients with impaired renal function:
    • Usual standard regimen for creatinine clearance above 30 mL/min.
    • ½ the usual regimen for creatinine clearance between 15 to 30 mL/min.
    • Use not recommended for creatinine clearance below 15 mL/min. 2

From the Research

Dosing for Bactrim DS

The recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for treating infections, particularly in patients with impaired renal function, is as follows:

  • The usual dosage for adults is 1 Bactrim DS (double strength) tablet or 2 Bactrim tablets every 12 hours 3.
  • For patients with impaired renal function, the dosage should be adjusted based on the creatinine clearance 4.
  • The following dosages are recommended for patients with renal impairment:
    • Creatinine clearance 30-50 mL/min: 1 Bactrim DS tablet every 12 hours
    • Creatinine clearance 15-29 mL/min: 1 Bactrim DS tablet every 24 hours
    • Creatinine clearance < 15 mL/min: not recommended

Considerations for Patients with Impaired Renal Function

  • Patients with impaired renal function are at increased risk of adverse outcomes, including acute kidney injury and hyperkalaemia, when treated with trimethoprim/sulfamethoxazole 4.
  • The risk of adverse outcomes is higher in patients taking renin-angiotensin system blockers and potassium-sparing diuretics 4.
  • Close monitoring of renal function and electrolyte levels is recommended in patients with impaired renal function who are treated with trimethoprim/sulfamethoxazole 4.

Resistance Rates and Treatment Guidelines

  • Resistance rates to trimethoprim/sulfamethoxazole vary by region and can be as high as 34% 5.
  • Guidelines recommend trimethoprim/sulfamethoxazole for empirical treatment of uncomplicated UTIs unless resistance rates in the community exceed 10% to 20% 3.
  • Alternative antibiotics, such as fluoroquinolones or nitrofurantoin, may be considered in areas with high resistance rates or in patients with impaired renal function 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.